Yi-Chiang Hsu

16PUBLICATIONS
14CO-AUTHORS
Molecular medicineMolecular targetsCancer cell biologyNatural products and bioactive compoundsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 25, 2025
Tetrahydrocurcumin (THC) as a Melanogenesis Inhibitor in Melanoma Cell Lines.

Yung-Shun Su, Kuan-Ting Lee, Yi-Chiang Hsu

|Aug 28, 2025
Cucurbitacin E Suppresses Adipogenesis and Lipid Accumulation in 3T3-L1 Adipocytes Without Cytotoxicity.

Tien-Chou Soong, Kuan-Ting Lee, Yi-Chiang Hsu

|Aug 27, 2025
Repurposing a Lipid-Lowering Agent to Inhibit TNBC Growth Through Cell Cycle Arrest.

Yi-Chiang Hsu, Kuan-Ting Lee, Sung-Nan Pei

|Nov 25, 2023
JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells.

Tai-Hsin Tsai, Kuan-Ting Lee, Yi-Chiang Hsu

|May 27, 2023
A Novel Synthetic Oleanolic Acid Derivative Inhibits Glioma Cell Proliferation by Regulating Cell Cycle G2/M Arrest.

Tai-Hsin Tsai, Cheng-Yu Tsai, Sin-Hua Moi

Pageof 3